Biba Medical Limited - Accounts to registrar (filleted) - small 17.3

Biba Medical Limited - Accounts to registrar (filleted) - small 17.3


IRIS Accounts Production v17.3.1.106 02944429 Board of Directors Board of Directors 1.7.16 30.6.17 30.6.17 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure029444292016-06-30029444292017-06-30029444292016-07-012017-06-30029444292015-06-30029444292015-07-012016-06-30029444292016-06-3002944429ns15:EnglandWales2016-07-012017-06-3002944429ns14:PoundSterling2016-07-012017-06-3002944429ns10:Director12016-07-012017-06-3002944429ns10:Director22016-07-012017-06-3002944429ns10:PrivateLimitedCompanyLtd2016-07-012017-06-3002944429ns10:SmallEntities2016-07-012017-06-3002944429ns10:AuditExempt-NoAccountantsReport2016-07-012017-06-3002944429ns10:SmallCompaniesRegimeForDirectorsReport2016-07-012017-06-3002944429ns10:SmallCompaniesRegimeForAccounts2016-07-012017-06-3002944429ns10:FullAccounts2016-07-012017-06-3002944429ns10:CompanySecretary12016-07-012017-06-3002944429ns10:RegisteredOffice2016-07-012017-06-3002944429ns5:CurrentFinancialInstruments2017-06-3002944429ns5:CurrentFinancialInstruments2016-06-3002944429ns5:ShareCapital2017-06-3002944429ns5:ShareCapital2016-06-3002944429ns5:RevaluationReserve2017-06-3002944429ns5:RevaluationReserve2016-06-3002944429ns5:RetainedEarningsAccumulatedLosses2017-06-3002944429ns5:RetainedEarningsAccumulatedLosses2016-06-3002944429ns5:LandBuildingsns5:OwnedOrFreeholdAssets2016-07-012017-06-3002944429ns5:LeaseholdImprovements2016-07-012017-06-3002944429ns5:FurnitureFittings2016-07-012017-06-3002944429ns5:ComputerEquipment2016-07-012017-06-3002944429ns5:LandBuildings2016-06-3002944429ns5:LeaseholdImprovements2016-06-3002944429ns5:FurnitureFittings2016-06-3002944429ns5:ComputerEquipment2016-06-3002944429ns5:LandBuildings2016-07-012017-06-3002944429ns5:LandBuildings2017-06-3002944429ns5:LeaseholdImprovements2017-06-3002944429ns5:FurnitureFittings2017-06-3002944429ns5:ComputerEquipment2017-06-3002944429ns5:LandBuildings2016-06-3002944429ns5:LeaseholdImprovements2016-06-3002944429ns5:FurnitureFittings2016-06-3002944429ns5:ComputerEquipment2016-06-3002944429ns5:CostValuation2016-06-3002944429ns5:DisposalsRepaymentsInvestments2017-06-3002944429ns5:CostValuation2017-06-3002944429ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-06-3002944429ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-06-30


REGISTERED NUMBER: 02944429 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2017

for

Biba Medical Limited

Biba Medical Limited (Registered number: 02944429)






Contents of the Financial Statements
for the Year Ended 30 June 2017




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Biba Medical Limited

Company Information
for the Year Ended 30 June 2017







DIRECTORS: S J Greenhalgh
R M Greenhalgh MA MD MChir FRCS





SECRETARY: K M Greenhalgh





REGISTERED OFFICE: 526 Fulham Road
London
SW6 5NR





REGISTERED NUMBER: 02944429 (England and Wales)





ACCOUNTANTS: Grunberg & Co Limited
Chartered Accountants
10-14 Accommodation Road
Golders Green
London
NW11 8ED

Biba Medical Limited (Registered number: 02944429)

Statement of Financial Position
30 June 2017

2017 2016
as restated
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,511,079 1,569,851
Investments 5 - 27,886
Investment property 6 1,536,134 1,530,150
3,047,213 3,127,887

CURRENT ASSETS
Debtors 7 834,919 756,437
Cash at bank 787,070 332,450
1,621,989 1,088,887
CREDITORS
Amounts falling due within one year 8 1,129,988 1,532,209
NET CURRENT ASSETS/(LIABILITIES) 492,001 (443,322 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,539,214

2,684,565

PROVISIONS FOR LIABILITIES 100,279 109,936
NET ASSETS 3,438,935 2,574,629

CAPITAL AND RESERVES
Called up share capital 2,000 2,000
Other reserves 9 82,663 82,663
Retained earnings 3,354,272 2,489,966
SHAREHOLDERS' FUNDS 3,438,935 2,574,629

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

Biba Medical Limited (Registered number: 02944429)

Statement of Financial Position - continued
30 June 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 30 November 2017 and were signed on its behalf
by:




S J Greenhalgh - Director



R M Greenhalgh MA MD MChir FRCS - Director


Biba Medical Limited (Registered number: 02944429)

Notes to the Financial Statements
for the Year Ended 30 June 2017

1. STATUTORY INFORMATION

Biba Medical Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services, excluding value added tax. Income is recognised at the point
of provision of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Improvements to property - 20% on cost
Fixtures and fittings - between 25% and 33% on cost
Computer equipment - 33% on cost

Investment property
Investment property is included at fair value. Gains are recognised in the income statement. Deferred taxation is
provided on these gains at the rate expected to apply when the property is sold.

Financial instruments
Debtors - short term debtors are measured at transaction price, less any impairment.

Creditors - short term creditors are measured at transaction price.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Biba Medical Limited (Registered number: 02944429)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2017

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of
exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating
result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Investments
Investments held as fixed assets are stated at cost less any provisions for impairment. Investments are reviewed
for impairment if events or circumstances indicate that the carrying value may not be recoverable in full.
Impairments are calculated such that the carrying value of the fixed asset investment is the lower of cost or the
recoverable amount, being its net realisable value in use.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2016 - 28 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
Freehold to and Computer
property property fittings equipment Totals
£    £    £    £    £   
COST
At 1 July 2016 1,481,365 229,624 121,377 11,849 1,844,215
Additions - 12,078 4,819 8,053 24,950
At 30 June 2017 1,481,365 241,702 126,196 19,902 1,869,165
DEPRECIATION
At 1 July 2016 46,407 121,766 96,984 9,207 274,364
Charge for year 18,741 48,340 10,035 6,606 83,722
At 30 June 2017 65,148 170,106 107,019 15,813 358,086
NET BOOK VALUE
At 30 June 2017 1,416,217 71,596 19,177 4,089 1,511,079
At 30 June 2016 1,434,958 107,858 24,393 2,642 1,569,851

Included in cost of land and buildings is freehold land of £ 488,518 (2016 - £ 488,518 ) which is not depreciated.

Biba Medical Limited (Registered number: 02944429)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2017

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 July 2016 27,886
Disposals (27,886 )
At 30 June 2017 -
NET BOOK VALUE
At 30 June 2017 -
At 30 June 2016 27,886

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 July 2016 1,530,150
Additions 5,984
At 30 June 2017 1,536,134
NET BOOK VALUE
At 30 June 2017 1,536,134
At 30 June 2016 1,530,150

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
as restated
£    £   
Trade debtors 702,499 646,588
Other debtors 75,876 58,992
Prepayments and accrued income 56,544 50,857
834,919 756,437

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
as restated
£    £   
Trade creditors 212,462 243,202
Corporation tax 220,358 192,031
Social security and other taxes 82,373 93,956
Other creditors 201,095 541,738
Directors' current accounts 1,282 -
Accruals and deferred income 412,418 461,282
1,129,988 1,532,209

Biba Medical Limited (Registered number: 02944429)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2017

9. RESERVES

Other reserves relates to the unrealised fair value movements on the company's investment property and are not
distributable.

10. RELATED PARTY DISCLOSURES

Included in other creditors is an amount of £185,277 (2016 - £490,000) owed to a related party in which the
directors act as trustees. The amount is an interest free and repayable on demand.

11. FIRST YEAR ADOPTION

These are the first financial statements that comply with FRS 102 Section 1A small entities. The date of transition
was 1 July 2015.

On transition to compliance with Financial Reporting Standard 102 the treatment for the deferred tax provision
was reviewed. In the prior year, under UK GAAP reporting standard, recognition of deffered tax on revalued
fixed assets was prohibited, unless there was a commitment to sell that fixed asset. Under FRS 102, a deferred tax
provision must be recognised on investment property, that is measured at fair value, irrespective of whether the
asset is likely to be sold. An increase in the deferred tax provision of £19,390 has been recognised in the
comparative figures as a transitional adjustment, decreasing reserves by the same amount. This adjustment did not
impact the company's retained earnings.